市場調査レポート
商品コード
1068715

アテローム性動脈硬化症治療薬の世界市場(2022年~2026年)

Global Atherosclerosis Therapeutics Market 2022-2026

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.28円
アテローム性動脈硬化症治療薬の世界市場(2022年~2026年)
出版日: 2022年03月30日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のアテローム性動脈硬化症治療薬の市場規模は、2022年から2026年の予測期間中に5.66%のCAGRで推移し、34億4,000万米ドルの成長が見込まれています。

同市場の成長を後押しする主な要因には、動脈硬化のリスク要因の増加、高度な診断方法の利用可能性、高コレステロール血症の有病率の上昇などが挙げられます。

当レポートでは、世界のアテローム性動脈硬化症治療薬市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および課題、顧客情勢、製品・地域別の分析、さらにベンダー情勢およびベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:2021年から2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースサマリー
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第5章 製品別の市場セグメンテーション

  • 市場内訳
  • 製品別の比較
  • 小分子:市場規模と予測(2021年~2026年)
  • 生物製剤:市場規模と予測(2021年~2026年)
  • 製品別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域:市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • 英国:市場規模と予測(2021年~2026年)
  • 中国:市場規模と予測(2021年~2026年)
  • ドイツ:市場規模と予測(2021年~2026年)
  • 地域情勢別の市場機会

第8章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱情勢
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Amgen Inc.
  • AstraZeneca Plc
  • Dr. Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Viatris Inc.

第11章 付録

  • 調査範囲
  • 包含と除外のチェックリスト
  • 米ドルの為替レート
  • 調査手法
  • 略語のリスト
目次
Product Code: IRTNTR73034

Technavio has been monitoring the atherosclerosis therapeutics market and it is poised to grow by $ 3.44 bn during 2022-2026 progressing at a CAGR of 5.66% during the forecast period. Our report on the atherosclerosis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing risk factors for atherosclerosis, the availability of advanced diagnostic methods, and the rising prevalence of hypercholesterolemia.

The atherosclerosis therapeutics market analysis includes the product segment and geographic landscape.

Technavio's atherosclerosis therapeutics market is segmented as below:

By Product

  • Small molecules
  • Biologics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the identification of new pathogenic targets as one of the prime reasons driving the atherosclerosis therapeutics market growth during the next few years. Also, identification of new drug targets for atherosclerosis and strong incidence of coronary heart disease (CHD) will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on atherosclerosis therapeutics market covers the following areas:

  • Atherosclerosis therapeutics market sizing
  • Atherosclerosis therapeutics market forecast
  • Atherosclerosis therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading atherosclerosis therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Dr. Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ionis Pharmaceuticals Inc., Merck and Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Sanofi SA, Viatris Inc., GlaxoSmithKline Plc, and Pfizer Inc. Also, the atherosclerosis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

  • 5.1 Market segments
  • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
  • 5.2 Comparison by Product
  • Exhibit 26: Chart on Comparison by Product
  • Exhibit 27: Data Table on Comparison by Product
  • 5.3 Small molecules - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
  • 5.4 Biologics - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Product
  • Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.11 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Amgen Inc.
  • Exhibit 85: Amgen Inc. - Overview
  • Exhibit 86: Amgen Inc. - Product / Service
  • Exhibit 87: Amgen Inc. - Key offerings
  • 10.4 AstraZeneca Plc
  • Exhibit 88: AstraZeneca Plc - Overview
  • Exhibit 89: AstraZeneca Plc - Product / Service
  • Exhibit 90: AstraZeneca Plc - Key news
  • Exhibit 91: AstraZeneca Plc - Key offerings
  • 10.5 Dr. Reddys Laboratories Ltd.
  • Exhibit 92: Dr. Reddys Laboratories Ltd. - Overview
  • Exhibit 93: Dr. Reddys Laboratories Ltd. - Business segments
  • Exhibit 94: Dr. Reddys Laboratories Ltd. - Key offerings
  • Exhibit 95: Dr. Reddys Laboratories Ltd. - Segment focus
  • 10.6 Eli Lilly and Co.
  • Exhibit 96: Eli Lilly and Co. - Overview
  • Exhibit 97: Eli Lilly and Co. - Product / Service
  • Exhibit 98: Eli Lilly and Co. - Key offerings
  • 10.7 GlaxoSmithKline Plc
  • Exhibit 99: GlaxoSmithKline Plc - Overview
  • Exhibit 100: GlaxoSmithKline Plc - Business segments
  • Exhibit 101: GlaxoSmithKline Plc - Key news
  • Exhibit 102: GlaxoSmithKline Plc - Key offerings
  • Exhibit 103: GlaxoSmithKline Plc - Segment focus
  • 10.8 Merck and Co. Inc.
  • Exhibit 104: Merck and Co. Inc. - Overview
  • Exhibit 105: Merck and Co. Inc. - Business segments
  • Exhibit 106: Merck and Co. Inc. - Key news
  • Exhibit 107: Merck and Co. Inc. - Key offerings
  • Exhibit 108: Merck and Co. Inc. - Segment focus
  • 10.9 Novartis AG
  • Exhibit 109: Novartis AG - Overview
  • Exhibit 110: Novartis AG - Business segments
  • Exhibit 111: Novartis AG - Key offerings
  • Exhibit 112: Novartis AG - Segment focus
  • 10.10 Pfizer Inc.
  • Exhibit 113: Pfizer Inc. - Overview
  • Exhibit 114: Pfizer Inc. - Product / Service
  • Exhibit 115: Pfizer Inc. - Key news
  • Exhibit 116: Pfizer Inc. - Key offerings
  • 10.11 Sanofi SA
  • Exhibit 117: Sanofi SA - Overview
  • Exhibit 118: Sanofi SA - Business segments
  • Exhibit 119: Sanofi SA - Key news
  • Exhibit 120: Sanofi SA - Key offerings
  • Exhibit 121: Sanofi SA - Segment focus
  • 10.12 Viatris Inc.
  • Exhibit 122: Viatris Inc. - Overview
  • Exhibit 123: Viatris Inc. - Business segments
  • Exhibit 124: Viatris Inc. - Key offerings
  • Exhibit 125: Viatris Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Product - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Product - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Product
  • Exhibits27: Data Table on Comparison by Product
  • Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Product ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: Amgen Inc. - Overview
  • Exhibits86: Amgen Inc. - Product / Service
  • Exhibits87: Amgen Inc. - Key offerings
  • Exhibits88: AstraZeneca Plc - Overview
  • Exhibits89: AstraZeneca Plc - Product / Service
  • Exhibits90: AstraZeneca Plc - Key news
  • Exhibits91: AstraZeneca Plc - Key offerings
  • Exhibits92: Dr. Reddys Laboratories Ltd. - Overview
  • Exhibits93: Dr. Reddys Laboratories Ltd. - Business segments
  • Exhibits94: Dr. Reddys Laboratories Ltd. - Key offerings
  • Exhibits95: Dr. Reddys Laboratories Ltd. - Segment focus
  • Exhibits96: Eli Lilly and Co. - Overview
  • Exhibits97: Eli Lilly and Co. - Product / Service
  • Exhibits98: Eli Lilly and Co. - Key offerings
  • Exhibits99: GlaxoSmithKline Plc - Overview
  • Exhibits100: GlaxoSmithKline Plc - Business segments
  • Exhibits101: GlaxoSmithKline Plc - Key news
  • Exhibits102: GlaxoSmithKline Plc - Key offerings
  • Exhibits103: GlaxoSmithKline Plc - Segment focus
  • Exhibits104: Merck and Co. Inc. - Overview
  • Exhibits105: Merck and Co. Inc. - Business segments
  • Exhibits106: Merck and Co. Inc. - Key news
  • Exhibits107: Merck and Co. Inc. - Key offerings
  • Exhibits108: Merck and Co. Inc. - Segment focus
  • Exhibits109: Novartis AG - Overview
  • Exhibits110: Novartis AG - Business segments
  • Exhibits111: Novartis AG - Key offerings
  • Exhibits112: Novartis AG - Segment focus
  • Exhibits113: Pfizer Inc. - Overview
  • Exhibits114: Pfizer Inc. - Product / Service
  • Exhibits115: Pfizer Inc. - Key news
  • Exhibits116: Pfizer Inc. - Key offerings
  • Exhibits117: Sanofi SA - Overview
  • Exhibits118: Sanofi SA - Business segments
  • Exhibits119: Sanofi SA - Key news
  • Exhibits120: Sanofi SA - Key offerings
  • Exhibits121: Sanofi SA - Segment focus
  • Exhibits122: Viatris Inc. - Overview
  • Exhibits123: Viatris Inc. - Business segments
  • Exhibits124: Viatris Inc. - Key offerings
  • Exhibits125: Viatris Inc. - Segment focus
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations